@article {Matvienko-Sikar2021.01.17.21249963, author = {Karen Matvienko-Sikar and Kate N O{\textquoteright} Neill and Abigail Fraser and Catherine Hayes and Laura D Howe and Anja C Huizink and Patricia M Kearney and Ali Khashan and Sarah Redsell and Linda M O{\textquoteright}Keeffe}, title = {Maternal prenatal anxiety and depression and trajectories of cardiometabolic risk factors across childhood and adolescence: a prospective cohort study}, elocation-id = {2021.01.17.21249963}, year = {2021}, doi = {10.1101/2021.01.17.21249963}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background Quantifying long-term offspring cardiometabolic health risks associated with maternal prenatal anxiety and depression can guide cardiometabolic risk prevention. This study examines associations between maternal prenatal anxiety and depression, and offspring cardiometabolic risk from birth to 18 years.Methods Participants were 526-8,606 mother-offspring pairs from the Avon Longitudinal Study of Parents and Children (ALSPAC). Exposures were anxiety (Crown-Crisp Inventory score) and depression (Edinburgh Postnatal Depression Scale score) measured at 18 and 32 weeks gestation. Outcomes were trajectories of offspring body mass index; fat mass; lean mass; pulse rate; glucose, diastolic and systolic blood pressure; triglycerides, high-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol, and insulin from birth/early childhood to 18 years. Exposures were analysed categorically using clinically relevant, cut-offs and continuously to examine associations across the distribution of prenatal anxiety and depression.Results We found no strong evidence of associations between maternal anxiety and depression, and offspring trajectories of any cardiometabolic risk factors, except for small, inconsistent associations with fat mass trajectories that attenuated upon confounder adjustment. For instance, in unadjusted analyses, anxiety at both 18 and 32 weeks was associated with a 1.8\% (95\% Confidence Interval (CI), 0.29,3.33) higher mean BMI, which spanned the null (difference (95\% CI): 0.7\% (-0.76,2.13) after adjustment for confounders.Conclusions This is the first examination of maternal prenatal anxiety and depression and trajectories of offspring cardiometabolic risk. Our findings suggest that prevention of maternal prenatal anxiety and depression may have limited impact on offspring cardiometabolic health across the first two decades of life.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and KMS and LMOK will serve as guarantors for the contents of this paper. KMS is supported by a Health Research Board of Ireland (HRB) Applying Research to Policy and Practice award (HBR-ARPP-A011). LMOK and KON are supported by a HRB Emerging Investigator Award (EIA-2019-007). KON is also supported by a HRB Research Leader Award (RL/2013/7) and a HRB Interdisciplinary Capacity Enhancement Award (HRB ICE 2015-1026). LDH and AF are supported by Career Development Awards from the UK Medical Research Council (grants MR/M020894/1 and MR/M009351/1, respectively). LDH and AF work in a unit that receives funds from the UK Medical Research Council (grant MC_UU_00011/3, MC_UU_00011/6). The research funders had no role in the study design; data collection, analysis, and interpretation of data; writing of the manuscript; or the decision to submit the manuscript for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used in this study was from the Avon Longitudinal Study of Parents and Children (ALSPAC), requests for access to this data can be made to the ALSPAC executive committee.}, URL = {https://www.medrxiv.org/content/early/2021/01/20/2021.01.17.21249963}, eprint = {https://www.medrxiv.org/content/early/2021/01/20/2021.01.17.21249963.full.pdf}, journal = {medRxiv} }